Laser at 924/975 + Curettage Best for Axillary Hyperhidrosis

This article originally appeared here.
Share this content:
Laser at 924/975 + Curettage Best for Axillary Hyperhidrosis
Laser at 924/975 + Curettage Best for Axillary Hyperhidrosis

FRIDAY, Feb. 27, 2015 (HealthDay News) -- For patients with axillary hyperhidrosis, the optimal treatment option is laser at 924/975 nm combined with curettage, according to a study published online Feb. 6 in Lasers in Surgery and Medicine.

Franck Marie Leclère, M.D., Ph.D., from the CHU University of Bordeaux in France, and colleagues conducted a randomized prospective controlled trial involving 100 patients with axillary hyperhidrosis. Patients were treated with laser alone at 975 nm (group 1); laser alone at 924/975 nm simultaneously (group 2); curettage alone (group 3); and laser at 924/975 nm followed by curettage (group 4).

The researchers found that two patients from group 1 experienced burns which took more than one month to heal. The worse results were achieved in group 1; at one and 12 months after treatment, the starch test scale results were 2.48 and 2.76, respectively, while the Global Aesthetic Improvement Scale (GAIS) results were 1.04 and 0.92. The corresponding starch test scale results were 1.36 and 1.48 in group 2, and the corresponding GAIS results were 2.36 and 2.72. The starch test scale results were 1.56 and 1.76, respectively, in group 3, corresponding with small to substantially smaller dark areas; the GAIS results were 2.28 and 2.64, respectively. Group 4 obtained the best results: the starch scale test scores were 0.40 and 0.44, respectively, while the GAIS scores were 3.72 and 3.76.

"This treatment was safe, with few side effects and improvement that persisted to one year follow-up," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »